Sort
21,281 grants matching “influenza”
Development of a novel adjuvant for vaccine sparing
$1,248,398Sara Lustigman · New York Blood Center · R01 · FY2017 · AI
Proteomics, Metabolomics and Lipidomics
$1,247,952Richard D Smith · University Of Wisconsin-Madison · U19 · FY2013 · AI
Innate inflammatory responses during pulmonary infections
$1,247,742Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Immune Function and Biodefense in Immunocrompromised Populations
$1,246,937Erol Fikrig · Yale University · N01 · FY2010 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens
$1,246,735Deborah Anne Dean · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · AI
Towards a predictive understanding of influenza immunity through experimental data integration, iterative model development, and rigorous assessment of model quality
$1,246,617Bjoern Peters · La Jolla Institute For Immunology · U01 · FY2025 · AI
Immune Function and Biodefense in Children, Elderly, and Immunocrompromised
$1,245,000Icahn School Of Medicine At Mount Sinai · N01 · FY2009 · AI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population
$1,245,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2014 · IP
Vaccine and Treatment Evaluation Units
$1,244,414Nadine Georges Rouphael · Emory University · UM1 · FY2023 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,244,356Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2006 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,243,982Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Task A47: Development of Ferret and Hamster Reagents for Immunological Studies
$1,243,577Saul Tzipori · Tufts University Boston · N01 · FY2020 · AI
University of Rochester Vaccine and Treatment Evaluation Unit(VTEU)-DMID 21-0012
$1,242,949Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Innate inflammatory responses during pulmonary infections
$1,242,800Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Virulence Evolution After Viral Host Jump and Emergence
$1,242,443Andrew R Wargo · College Of William & Mary Virginia Institute Of Marine Science · · FY2018 · BIO
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
$1,239,966Wayne M Sullender · University Of Alabama At Birmingham · U01 · FY2008 · IP
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,239,603Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Comparative Study of Influenza Vaccines in Adults
$1,239,569University Of Michigan At Ann Arbor · U01 · FY2004 · AI
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
$1,238,693Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2022 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$1,238,541Deborah L. Fuller · Albany Medical College · U01 · FY2009 · AI
Inhaled Large Porous Particles for Treatment of MDR-TB
$1,237,893Harvard University · U01 · FY2004 · AI
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$1,236,847Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
SURVEILLANCE & RESPONSE TO SEASONAL & PANDEMIC INFLUENZA IN REGION OF THE AMERICA
$1,236,529Marcos Espinal · Pan American Health Organization · U51 · FY2012 · IP
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
$1,235,411Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2021 · AI
The "Dynamics of the immune responses to repeat influenza vaccination exposures" (DRIVE) Study
$1,235,066Sarah Cobey · University Of Chicago · U01 · FY2023 · AI